Xylan microparticles for controlled release of mesalamine: Production and physicochemical characterization

Carbohydr Polym. 2020 Dec 15:250:116929. doi: 10.1016/j.carbpol.2020.116929. Epub 2020 Aug 17.

Abstract

Xylan extracted from corn cobs was used to produce mesalamine-loaded xylan microparticles (XMP5-ASA) by cross-linking polymerization using a non-hazardous cross-linking agent. The microparticles were characterized by thermal analysis (DSC/TG), X-ray diffraction (XRD), Infrared spectroscopy (FTIR-ATR) and scanning electron microscopy (SEM). A comparative study of the in vitro drug release from XMP5-ASA and from gastro-resistant capsules filled with XMP5-ASA (XMPCAP5-ASA) or 5-ASA was also performed. NMR, FTIR-ATR, XRD and DSC/TG studies indicated molecularly dispersed drug in the microparticles with increment on drug stability. The release studies showed that XMPCAP5-ASA allowed more efficient drug retention in the simulated gastric fluid and a prolonged drug release lasting up to 24 h. XMPCAP5-ASA retained approximately 48 % of its drug content after 6 h on the drug release assay. Thus, the encapsulation of 5-ASA into xylan microparticles together with gastro-resistant capsules allowed a better release control of the drug during different simulated gastrointestinal medium.

Keywords: Biopolymer; DDsolver; Drug delivery systems; Hemicellulose; Mesalamine (PubChem CID 4075); Mesalazine; Sodium trimetaphosphate (PubChem CID 24579).

MeSH terms

  • Chitosan / chemistry*
  • Computer Simulation*
  • Delayed-Action Preparations*
  • Drug Delivery Systems
  • Drug Liberation*
  • Gastrointestinal Tract / physiology*
  • Humans
  • Mesalamine / metabolism*
  • Models, Biological
  • Particle Size
  • Xylans / chemistry*

Substances

  • Delayed-Action Preparations
  • Xylans
  • Mesalamine
  • Chitosan